Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Articles
Leukemia
Bosutinib Shows Superior Results in CML
Read More
Leukemia
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Read More
Multiple Myeloma
,
Multiple Myeloma
VISTA Final Analysis Upholds Survival Benefit of Bortezomib at 5 Years
Read More
Multiple Myeloma
,
Multiple Myeloma
Maintenance Strategies in Elderly Patients with Myeloma Not Eligible for Transplant
Read More
Guidelines for Molecular/Cytogenetic Tests Can Eliminate Overordering, Reduce Costs
Read More
Conference Highlights ASH
Ready-Made Platelets? A Boon for Patients If It Works
Read More
Cost of Treating Myeloproliferative Neoplasms Is Significant
Read More
Conference Highlights ASH
High Morbidity Burden Borne Years Later by Survivors of Transplant
Read More
Leukemia
Obinutuzumab Could Give Rituximab a Run for Its Money in Relapsed Indolent NHL
Read More
Leukemia
Maintenance Rituximab May Be Unnecessary in FL
Read More
206
207
208
209
210
211
212
Page 209 of 246
Results 2081 - 2090 of 2456